LAUSR

Given increasing prevalence of multi-drug resistant organisms (MDROs), there is a significant interest in exploring non-antibiotic therapeutic options. We discuss basics of bacteriophage therapy (BT) and its role in the treatment of infections due to MDRO. BT employs lytic viruses to infect and lyse bacterial pathogens and is an emerging treatment strategy for treatment of infections caused by MDROs. We summarize key characteristics that make BT an attractive option against MDROs, discuss recent cases in which BT was successfully used to treat antibiotic recalcitrant infections, and discuss challenges that need to be overcome to make BT a viable clinical strategy. BT is a viable therapeutic option needing further research in order to bring it to clinical practice.